Recombinant SALL4 anticorps (AA 100-300)
Aperçu rapide pour Recombinant SALL4 anticorps (AA 100-300) (ABIN7869856)
Antigène
Voir toutes SALL4 AnticorpsType d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Application
Classe de qualité
Clone
-
-
Épitope
- AA 100-300
-
Fonction
- Sal-like 4 Antibody / SALL4 (azide and preservative free)
-
Purification
- Protein A affinity
-
Immunogène
- A recombinant partial protein sequence (within amino acids 100-300) from the human protein was used as the immunogen for the Sal-like 4 antibody.
-
Isotype
- IgG, kappa
-
-
-
-
Indications d'application
- Optimal dilution of the Sal-like 4 antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Agent conservateur
- Azide free
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Aliquot the Sal-like 4 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- SALL4 (Sal-Like 4 (SALL4))
-
Autre désignation
- Sal-like 4
-
Sujet
- Sall3 (SALL3, sal-like 3) and Sall4 (SALL4, sal-like 4) are mammalian homologs of the Drosophila region-specific homeotic gene spalt, which encodes a zinc finger-containing transcription regulator. Drosophila spalt is an essential genetic component required for the specification of posterior head and anterior tail as opposed to trunk. Sall3 is expressed at 24 weeks of gestation in several regions of the human fetal brain including neurons of the hippocampus formation and of mediodorsal and ventrolateral thalamic nuclei, Purkinje cells of the cerebellum, and a subset of neurons in the brainstem. Sall4 expression in early mouse embryos is gradually confined to the head region and the primitive streak, followed by prominent expression in the developing midbrain, branchial arches, limbs and genital papilla.
-
UniProt
- Q9UJQ4
-
Pathways
- Stem Cell Maintenance, Tube Formation
Antigène
-